Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial
Odile Launay, Christine Sadorge, Nathalie Jolly, Béatrice Poirier, Stéphane Béchet, Diane van der Vliet, Valérie Seffer, Nicola Fenner, Kelly Dowling, Raphaela Giemza, Julie Johnson, Anna Ndiaye, MuriVolume:
27
Year:
2009
Language:
english
DOI:
10.1016/j.vaccine.2008.12.021
File:
PDF, 795 KB
english, 2009